UPCC 19924 Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations for Older Adults with Cancer over 70 (PACE-70): A Hybrid Implementation-Effectiveness Study

Enrolling By Invitation
99 years or below
All
Phase N/A
140 participants needed
1 Location

Brief description of study

3 OBJECTIVES AND ENDPOINTS
Primary and secondary outcomes will be assessed using routinely collected electronic health record data at Penn Medicine Princeton Medical Center, Pennsylvania Hospital, and Penn Medicine Lancaster General Hospital. Exploratory outcomes will be assessed among those consenting to correlative analyses using additional data collected from participant step count monitoring, radiology studies, and questionnaires. Primary outcome: The proportion of eligible patients with a completed geriatric assessment within 30 days of initial oncology visit. Secondary outcome: The proportion of patients with geriatric impairment whose initial cycle of systemic therapy is dose modified.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 24-1457
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator